Navigation Links
Positive results in Phase 2 trial of treatment of C-difficile-associated diarrhea
Date:11/3/2008

Princeton, N.J. and Jamaica Plain, Mass., November 3, 2008 Medarex, Inc. (Nasdaq: MEDX) and The Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) today announced that a Phase 2 trial of an anti-C. difficile antibody combination treatment in patients with C. difficile Associated Diarrhea (CDAD) successfully met its primary objective. The top-line results from the recently completed multi-center, randomized, double-blind, placebo-controlled Phase 2 trial indicated a statistically significant reduction in recurrences of CDAD when compared with placebo. In the study, 200 patients symptomatic with CDAD receiving standard of care antibiotics (metronidazole or vancomycin) were randomized to receive either intravenous placebo or intravenous administration of a combination of MDX-066 (CDA-1) and MDX-1388 (CDB-1), two fully human antibodies that neutralize C. difficile toxins A and B, respectively.

Consistent with the published literature, the recurrence rate in the placebo-treated group exceeded 20 percent for patients following successful treatment with standard of care antibiotics. In comparison with placebo, MDX-066/MDX-1388 treatment reduced recurrence rates by approximately 70 percent (p=0.0004 on the intent-to-treat population). The antibody combination treatment was generally safe and well-tolerated. Full results from this Phase 2 trial are planned to be presented at a future scientific meeting.

The incidence and mortality associated with CDAD has been increasing , with estimates of over 500,000 cases in the United States, and approximately 15,000 deaths caused or contributed by C. difficile. The emergence of a highly virulent epidemic strain that produces much higher levels of toxins A and B has also been associated with morbidity and mortality in younger, healthier, and non-hospitalized patients.

"We are delighted with these dramatic results. CDAD is a gr
'/>"/>

Contact: Michael Cohen
michael.cohen@umassmed.edu
508-868-4778
University of Massachusetts Medical School
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Oral rinses used for tracking HPV-positive head and neck cancers holds promise for cancer screening
2. Vaccine against HER2-positive breast cancer offers complete protection in lab
3. Dry Tortugas show positive trends: Protected area slowly rebounding
4. Men unaware of their cancer risk when female relatives test positive for BRCA mutation
5. HGS announces positive Phase 2 LymphoStat-B at ACR meeting
6. Positive results for airway bypass
7. First results from hospital trials testing
8. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
9. Synaptics Reports Record Results for First Quarter of Fiscal 2009
10. Synaptics to Report First Quarter Results on October 23
11. Prosthetic vein valve designed to direct blood flow shows promising pre-clinical results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 11, 2014 The increased risk of kidney injury ... resuscitation fluids reflects the mass of HES molecules, according ... official journal of the International Anesthesia Research Society (IARS). ... harmful effect of HES on cultured human renal proximal ... Christian Wunder and colleagues of University Hospital Wrzburg, Austria. ...
(Date:7/11/2014)... that under the normal circumstances, astrocytes participate ... neuronal environment, and exhibit therapeutic and repairing ... Previous studies have found that nerve cells ... induction have reduced viability, which produces influences ... Yuan, Kailuan General Hospital, Hebei United University, ...
(Date:7/11/2014)... that let nerve cells send out electrical signals, Johns ... tactic that may offer a new way to protect ... responsible way. , Their findingthat naturally occurring insect ... for a closely related onesuggests that insecticides can be ... like bees. A summary of the research, led by ...
Breaking Biology News(10 mins):In lab studies, hydroxyethyl starch has direct harmful effects on kidney cells 2Potent spider toxin 'electrocutes' German, not American, cockroaches 2Potent spider toxin 'electrocutes' German, not American, cockroaches 3
... KNOXVILLE -- Birds are commonly thought of as being ... mate for life. Yet, in most bird species, some ... tending the nest. Why would a bird invest ... seem to provide no evolutionary advantage? Many scientists are ...
... In 1996, an international team of scientists led by ... paleontological survey in the cave of El Mirn. Since then ... bones and teeth of small vertebrates that lived in the ... of the Quaternary. The richness, great diversity and good conservation ...
... A new study has identified a specific class ... babies vulnerable to Sudden Infant Death Syndrome (SIDS), because ... at McMaster University, exposure of the fetus to nicotine ... oxygenknown as hypoxiawhich may result in a higher incidence ...
Cached Biology News:Biologists consider unifying framework to explain evolutionary puzzles 2Cantabrian cornice has experienced seven cooling and warming phases over past 41,000 years 2Simple drug treatment may prevent nicotine-induced SIDS: Study 2
(Date:7/10/2014)... Robert Harman, DVM, Founder and CEO of ... to announce the relaunch of his highly informative blog, now ... called “ What are Stem Cells ?” Dr. Harman’s ... foundation in the basics of stem cell therapy so that ... type of treatment when considering regenerative medicine. , A veterinarian ...
(Date:7/10/2014)... QC (PRWEB) July 10, 2014 EvoDerma ... and convenience. This rejuvenating device now comes with a second ... develops over time. , The new cup is thinner on ... design works to target rough, thin and uneven surfaces on ... firm cup for a stimulating treatment on areas such as ...
(Date:7/10/2014)... Ind. , July 10, 2014 /PRNewswire/ ... its use of capnography for respiratory monitoring ... group of healthcare leaders in embracing state-of-the-art ... how effectively patients are breathing and can ... occurs. By measuring the amount of carbon ...
(Date:7/10/2014)... DALLAS , July 10, 2014  Kainos Capital, ... consumer brands, today announced that it has acquired the ... stake in the business. Terms of the transaction were ... loss and meal replacement business that markets ready-to-drink shakes, ... North America and in the ...
Breaking Biology Technology:Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2Kainos Capital Acquires Slim-Fast From Unilever 2
... Madison, Wis. — To find the catalyst for ... years including the nation's astounding 26 percent gain ... and incentives, says University of Wisconsin Business School Dean ... productivity gains, well the responsibility clearly lies with information ...
... view of the planned Interdisciplinary Research Complex. Courtesy of ... Group. Madison, Wis. The Oscar ... of planned medical research facilities on the University of ... to build. , ,Called the Interdisciplinary Research Complex, the ...
... has installed its first volume computed tomography scanner, which takes ... cardiologist. , ,Round Rock Cardiology in Texas will use GE's ... GE said the scans take less time than five heartbeats. ... a three-dimensional view. , ,The scanner entered general clinical use ...
Cached Biology Technology:IT is critical for economic growth, says UW business dean 2IT is critical for economic growth, says UW business dean 3IT is critical for economic growth, says UW business dean 4
...
...
...
DryStrip aligners, 4. Category: Electrophoresis Systems & Standards & Reagents, IEF & SDS-PAGE & 2-D Electrophoresis, Multiphor II Kits & Components and Accessories....
Biology Products: